Sign up Australia
Proactive Investors - Run By Investors For Investors

Roto-Gro International deploying hydroponics to help grow organic cannabis

Delivery is expected to commence by the end of the year.
Roto-Gro International deploying hydroponics to help grow organic cannabis
The total order value is circa C$1.1 million

Roto-Gro International Ltd’s (ASX:RGI) shares were trading circa 19% higher intra-day after receiving a purchase order for 100 Roto-Gro hydroponic systems from Amfil Technologies Inc (OTCMKTS:AMFE).

The fully-automated Roto-Gro rotary hydroponic system (a method of growing plants without soil) can be used to produce high-quality medical cannabis at a competitive cost.

The new purchase order builds on Roto-Gro’s existing collaborative relationship with Amfil for the integration of Amfil’s proprietary GRO3 Antimicrobial System with the RotoGro System.

Importantly, the integration is expected to provide enhanced cultivation solutions for medical cannabis and indoor farming industries.

The successful signing of the purchase order is a result of the collaboration between Roto-Gro and Amfil over the past five months.

The 100 Roto-Gro Systems will be stacked two-high in 4,000 square feet of the first phase of a 40,000 square feet facility in Ontario, Canada to be developed by a Canadian organic cannabis cultivator.

The total order value is circa C$1.1 million, with delivery expected to commence by the end of the year.

In addition, the Canadian cultivator also operates a non-cannabis related nursery of perishable foods covering circa 150,000 square feet contained in several buildings on a single property.

Roto-Gro is currently discussing the design of a propriety rotary garden solution for the cultivator’s perishable food operations.

The company is aiming to assist the cultivator with a staged roll-out of a portion of these premises for perishable foods utilising the Roto-Gro System together with Amfil’s antimicrobial system.

Join our Crypto, Blockchain and Cannabis Telegram group here
View full RGI profile View Profile

RotoGro International Ltd Timeline

Related Articles

couple in bed
March 14 2018
MED2002 is a rapid onset gel designed for those men where the current pill-based treatments aren’t appropriate, or carry significant side-effects
surgeons working
September 03 2018
Chief executive Steve Couldwell also told investors the regenerative medicines specialist had identified a number of potential new commercial opportunities it was “actively pursuing”
Picture of growing facility
May 07 2018
Establishing a vertically integrated business model provides THC with the ability to optimise efficiencies in the manufacturing process.

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use